Cargando…
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/ https://www.ncbi.nlm.nih.gov/pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 |
_version_ | 1785097929421225984 |
---|---|
author | Lu, Jinmiao Ying, Xiaohua Li, Zhiping |
author_facet | Lu, Jinmiao Ying, Xiaohua Li, Zhiping |
author_sort | Lu, Jinmiao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10461880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-104618802023-08-29 Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance Lu, Jinmiao Ying, Xiaohua Li, Zhiping Int J Health Policy Manag Letter to Editor Kerman University of Medical Sciences 2023-06-18 /pmc/articles/PMC10461880/ /pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 Text en © 2023 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Lu, Jinmiao Ying, Xiaohua Li, Zhiping Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title_full | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title_fullStr | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title_full_unstemmed | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title_short | Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance |
title_sort | pricing new drugs for covid-19 in the pharmaceutical industry: insights from the chinese medical insurance |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/ https://www.ncbi.nlm.nih.gov/pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 |
work_keys_str_mv | AT lujinmiao pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance AT yingxiaohua pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance AT lizhiping pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance |